Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2000
03/28/2000US6043212 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
03/28/2000US6043211 Adding to a first protein a peptide analogue of a phosphorylated region, whereupon the binding of said first protein to said second protein is inhibited
03/28/2000US6043093 Directing evolution of molecule into one that reacts with a recognition sequence by expression in cells containing growth factor, modulation moiety and recognition sequence; mutagenizing; replication; selecting for modified growth
03/28/2000US6043091 Compound of 8 to 30 nucleobases targeted to coding region, 3' or 5'-untranslated region, or start codon of nucleic acid encoding a carbohydrate metabolism enzyme; for antidiabetic agents against non-insulin dependent diabetes
03/28/2000US6043090 Compound of 8 to 30 nucleotides targeted to a 3' or 5' untranslated region or coding region of nucleic acid which encodes human serine/threonine kinase; diagnosis, therapy, and prophylaxis of related diseases; anticancer agents
03/28/2000US6043088 Nucleotide sequence; dna and rna probes for diagnosis; anticarcinogenic/antitumor agents; vectors for gene therapy
03/28/2000US6043085 Nucleotide and amino acid sequences; for treatment of infections/bactericides
03/28/2000US6043084 Nucleotide sequences which encode a cancer associated antigen
03/28/2000US6043082 Two genetic constructs encoding chimeric proteins, each with ligand binding domain to complex with the other protein; one protein also with domain which induces biological process, the other having intracelluar targeting domain; gene therapy
03/28/2000US6043081 Expression vectors encoding recombinant proteins comprising a VPR/VPX virion incorporation domain for targeting into HIV-1 or HIV-2 virions
03/28/2000US6043080 One piece, multicompartment device having a chamber for amplification, one for fragmentation, and another with array of probes coupled to substrate
03/28/2000US6043077 Directed aganist specific nucleotide sequences to inhibit replication, infectivity, or gene expression of the virus; for prevention or viricides with side effect reduction
03/28/2000US6043075 Endoglucanase
03/28/2000US6043073 Phospholipase D polypeptide and DNA sequences
03/28/2000US6043072 Nucleic acids encoding Taxus geranylgeranyl diphosphate synthase, and methods of use
03/28/2000US6043071 GlmU
03/28/2000US6043070 With specific sequence of nucleotide linkages; for nucleic acid amplification reactions such as polymerase chain reactions and nucleic acid sequencing
03/28/2000US6043069 Catalytic antibodies and a method of producing same
03/28/2000US6043062 Constitutively active phosphatidylinositol 3-kinase and uses thereof
03/28/2000US6043060 Nucleotide analogues
03/28/2000US6043059 Performing series of reactions involving hybridizing primer to target and effecting chain extension/chain termination; using primer from presynthesized set having raised annealing temperature and/or improved annealing properties
03/28/2000US6043056 Amino acid sequences; for diagnosis, treatment, and prevention of blood, karyotypic, and nervous system disorders
03/28/2000US6043055 Amino acid sequence of bcl-2-related ovarian killer protein highly expressed in the ovary, testis and uterus; for antiproliferative/anticarcinogenic agents; gene therapy; gene mapping of functional regions of protein
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6043053 Wnt-3 polynucleotides
03/28/2000US6043052 Nucleotide and amino acid sequences of g protein coupled receptor; for diagnosis and treatment of related diseases; anticarcinogenic/antidiabetic/antiulcer agents; antidepressants; hypotensive/hypertensive agents
03/28/2000US6043051 Nucleotide sequence capable of transcriptional control by a pleiotropic drug resistance gene product and can be used in a complete nutrient medium
03/28/2000US6043041 Amplification and detection of Shiga-like toxin II producing organisms
03/28/2000US6043040 Csak-3 nucleic acid molecules and uses therefor
03/28/2000US6043039 Obtaining chromosome spread, preparing composite of chromosomal paints, denaturing composite and renaturing leaving unique sequences single-stranded, hybridizing to chromosomes, washing, analyzing and presenting images
03/28/2000US6043032 Simplified method with consistent efficiency without use of phenol/chloroform; mixing sample with carrier of dextran, acrylamide and/or carboxymethyl cellulose, coprecipitating and insolubilizing nucleic acids, separating from liquid
03/28/2000US6043031 DNA diagnostics based on mass spectrometry
03/28/2000US6043030 Cell-cycle regulatory proteins, and uses related thereto
03/28/2000US6043028 Method for synthesizing single-stranded stem-loop DNA's the products and uses therefore
03/28/2000US6042846 Resistant to nuclease hydrolysis; efficiency
03/28/2000US6042835 Prototype FelV isolates for use in disease models and vaccines
03/28/2000US6042833 Cellular internalization of pIgR stalk and associated ligands
03/28/2000US6042832 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
03/28/2000US6042827 Anti-idiotypic antibody induction of anti-tumor response
03/28/2000US6042825 A parasitic helminth asparaginase proteins; parasitic helminth asparaginase nucleic acid molecules that codes such asparaginase proteins
03/28/2000US6042821 Treating sepsis using chemokines which are a protein or polypeptide
03/28/2000CA2245903A1 Use of pex in the treatment of metabolic bone diseases
03/28/2000CA2140531C Method of increasing expression of viral proteins
03/28/2000CA2088683C Homogenous assay system
03/28/2000CA2023094C Efficient production of mutant proteases
03/28/2000CA1340935C Fc gamma receptor
03/28/2000CA1340934C Hepatitis b surface antigen formed by recombinant dna techniques, vaccines, diagnostics, cell lines and method of forming same
03/25/2000CA2246702A1 Pre-testing of dna constructs by trans-somatic techniques
03/24/2000CA2248396A1 Improved starchy flours
03/23/2000WO2000016089A2 Signal detection techniques for the detection of analytes
03/23/2000WO2000016087A1 Spectral calibration of fluorescent polynucleotide separation apparatus
03/23/2000WO2000016082A1 Device comprising a plurality of analysis sites on a support
03/23/2000WO2000016061A2 Method for diagnosing the active stage of a cytomegalovirus infection in human substrates
03/23/2000WO2000015853A1 Recombinant newcastle disease virus rna expression systems and vaccines
03/23/2000WO2000015851A1 Geometrical and hierarchical classification based on gene expression
03/23/2000WO2000015849A1 Artificial long terminal repeat vectors
03/23/2000WO2000015846A1 Zero background universal cloning method
03/23/2000WO2000015845A1 T-type calcium channel
03/23/2000WO2000015844A1 Nucleic acid sequencing with solid phase capturable terminators
03/23/2000WO2000015842A1 Method of isolation primer extension products with modular oligonucleotides
03/23/2000WO2000015841A1 Method and kit for detecting intrachromosome imbalance in inter phase nuclei and their applications
03/23/2000WO2000015840A1 Method for determining susceptibility to heart disease by screening polymorphisms in the vitamin d receptor gene
03/23/2000WO2000015839A1 Method for determining susceptibility to bone damage by screening polymorphisms in the vitamin d receptor gene
03/23/2000WO2000015838A2 Essential genes from c. albicans and a method for screening antimycotic substances using said genes
03/23/2000WO2000015833A1 Multiple sequencing method
03/23/2000WO2000015830A1 Process for enzymatically modifying pectin
03/23/2000WO2000015827A2 Bacterial strains for the production of 2-keto-l-gulonic acid
03/23/2000WO2000015826A2 Leptin induced genes
03/23/2000WO2000015825A1 Condensed plasmid-liposome complex for transfection
03/23/2000WO2000015824A1 Transfer method for specific cellular localisation of nucleic acids
03/23/2000WO2000015823A1 Alternatively targeted adenovirus
03/23/2000WO2000015822A1 Methods for treatment of degenerative retinal diseases
03/23/2000WO2000015821A1 Recombinant adenovirus for tissue specific expression in heart
03/23/2000WO2000015820A1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
03/23/2000WO2000015819A1 Packaging cell lines for hiv-derived retroviral vector particles
03/23/2000WO2000015818A2 Plant prohibitin genes and their use
03/23/2000WO2000015817A2 Stomatin-like genes and their use in plants
03/23/2000WO2000015816A2 Maize replication protein a
03/23/2000WO2000015815A1 Rac-like genes from maize and methods of use
03/23/2000WO2000015814A1 Maize sina orthologue-1 and uses thereof
03/23/2000WO2000015813A1 Methods for producing genetically modified plants, plant materials and plant products produced thereby
03/23/2000WO2000015812A1 Dna fragment having promoter function
03/23/2000WO2000015811A1 Dna fragment having promoter function
03/23/2000WO2000015810A1 Isoforms of starch branching enzyme ii (sbe-iia and sbe-iib) from wheat
03/23/2000WO2000015809A2 Uracil permease from arabidopsis as herbicidal target gene
03/23/2000WO2000015808A1 MAMMARY GLAND TISSUE-SPECIFIC EXPRESSION SYSTEM USING $G(b)-CASEIN PROMOTER SITE OF KOREAN NATIVE GOAT
03/23/2000WO2000015807A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000WO2000015806A1 Atp synthase subunit homolog
03/23/2000WO2000015805A1 Use of protein kinase kiaa0551 as pharmaceutical
03/23/2000WO2000015804A2 Method for production of peroxidases by use of a genetically modified host
03/23/2000WO2000015803A1 Immunoglobulin binding protein
03/23/2000WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000WO2000015801A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
03/23/2000WO2000015800A2 Rac-like genes and methods of use
03/23/2000WO2000015799A2 Rna-associated proteins
03/23/2000WO2000015798A2 Mammalian transforming growth factor beta - 9 (ztgfss9)
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015796A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/23/2000WO2000015795A2 Genes from human chromosome 11p15.5
03/23/2000WO2000015794A1 Human cell junction pdz protein
1 ... 3267 3268 3269 3270 3271 3272 3273 3274 3275 3276 3277 3278 3279 3280 3281 3282 3283 3284 3285 3286 3287 ... 4023